MediWound is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ofer Gonen, with a market cap of $228.4M.
Common questions about MediWound
MediWound is scheduled to report earnings for Q1 2026 on May 20, 2026. Analysts estimate revenue of $3.4M.
MediWound has approximately 88 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.